Related Experiment Videos

[Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia]

C Boqué¹, A Grañena

¹Servicio de Hematología Clínica, Institut Català d'Oncologia, L'Hospitalet, Barcelona.

Sangre

|July 10, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia.

Annals of hematology·2022

A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection.

Bone marrow transplantation·2021

miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk.

Leukemia·2020

[Effectiveness and safety of lenalidomide in myelofibrosis patients: a case series from the Spanish compassionate use program].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2013

Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors: the Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético).

Bone marrow transplantation·2005

Richter's syndrome after allogeneic stem cell transplantation for chronic lymphocytic leukaemia successfully treated by withdrawal of immunosuppression, and donor lymphocyte infusion.

Bone marrow transplantation·2003

See all related articles